Breakthrough pain in the management of chronic persistent pain syndromes

American Journal of Managed Care

Volumn 14, Issue SUPPL. 4, 2008, Pages

  Webster, Lynn R ^a  

^a Lifetree Clinical Research and Pain Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ALGORITHM; BREAKTHROUGH PAIN; CHRONIC PAIN; DISEASE DURATION; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG ABUSE; HUMAN; PAIN; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; PAIN;

EID: 44649113086     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. International Association for the Study of Pain, Subcommittee on Taxonomy. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Pain Suppl. 1986;3:S1-S226.
2. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
3. 11C]-carfentanil and positron emission tomography (PET). Pain. 2002;99:589-598.
4. de Wied M, Verbaten MN. Affective pictures processing, attention, and pain tolerance. Pain. 2001;90:163-172.
5. Meagher MW, Amau RC, Rhudy JL. Pain and emotion: effects of affective picture modulation. Psychosom Med. 2001;63:79-90.
6. Rhudy JL, Dubbert PM, Parker JD, Burke RS, Williams AE. Affective modulation of pain in substance-dependent veterans. Pain Med. 2006;7:483-500.
7. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41:273-281.
8. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81:129-134.
9. Becker N, Thomsen AB, Olsen AK, Sjøgren P, Bech P, Eriksen J. Pain epidemiology and health-related quality of life in patients with chronic non-malignant pain [in Danish]. Ugeskr Laeger. 1998;160:6816-6819.
10. Caraceni A, Martini C, Zecca E, et al; Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med. 2004;18:177-183.
11. Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage. 1998;16:179-183.
12. Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain. 2003;101:55-64.
13. Portenoy RK, Bennett DS, Rauck R, et al. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain. 2006;7:583-591.
14. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice. Palliat Med. 2001;15:243-246.
15. Baron R, Treede RD. Diagnosis of neuropathic pain [in German]. Dtsch Med Wochenschr. 2007;132:2139-2144.
16. Jayson MI. Why does acute back pain become chronic? BMJ. 1997;314:1639-1640.
17. Svendsen KB, Andersen S, Amason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain. 2005;9:195-206.
18. Bowsher D, Rigge M, Sopp L. Prevalence of chronic pain in the British population: a telephone survey of 1037 households. Pain Clinic. 1991;4:223-230.
19. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443-2454.
20. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119:121-126.
21. Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care. 2004;21:137-142.
22. America Speaks: Pain in America. 2003 survey conducted by Peter D. Hart Research Associates for Research!America. American Pain Foundation Web site. http://www.painfoundation.org/page.asp?file=Newsroom/PainSurveys.htm. Accessed October 12, 2007.
23. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64:107-114.
24. Brescia FJ, Portenoy RK, Ryan M, Krasnoff L, Gray G. Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol. 1992;10:149-155.
25. American Pain Foundation. Pain facts and figures. http://www.painfoundation.org/page.asp?file=Newsroom/PainFacts.htm. Accessed December 4, 2007.
26. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280:147-151.
27. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002;23:131-137.
28. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999;354:1248-1252.
29. National Cancer Institute. Dictionary of cancer terms. http://www.cancer.gov/dictionary/. Accessed January 17, 2008.
30. Højsted J, Nielsen PR, Eriksen J, Hansen OB, Sjøgren P. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study. Acta Anaesthesiol Scand. 2006;50:1290-1296.
31. Payne R. Recognition and diagnosis of breakthrough pain. Pain Med. 2007;8:S3-S7.
32. Davies AN. Cancer-related breakthrough pain. Br J Hosp Med (Lond). 2006;67:414-416.
33. Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther. 2000;17:70-80.
34. Passik SD, Kirsh KL, Whitcomb L, et al. Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manage. 2005;1:257-266.
35. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432-442.
36. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65-75.
37. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-1907.
38. Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94:135-140.
39. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88:791-804.
40. Storgaard H, Nielsen SD, Gluud C. The validity of the Michigan Alcoholism Screening Test (MAST). Alcohol Alcohol. 1994;29:493-502.
41. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. Br J Addict. 1989;84:301-307.
42. Davis LJ Jr, Hurt RD, Morse RM, O'Brien PC. Discriminant analysis of the Self-Administered Alcoholism Screening Test. Alcohol Clin Exp Res. 1987;11:269-273.
43. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003;4:182-185.
44. Webster LR, Dove B. Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners. North Branch, MN: Sunrise River Press; 2007.
45. Bennett D, Burton AW, Fishman S, et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2: management. P&T. 2005;30:354-361.
46. Abrahm JL. Nonpharmacologic strategies for pain and symptom management. In: Abrahm JL, ed. A Physician's Guide to Pain and Symptom Management in Cancer Patients. 2nd ed. Baltimore, MD: Johns Hopkins University Press; 2005:279-316.
47. Mercadante S, Radbruch L, Caraceni A, et al; Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer. 2002;94:832-839.
48. Fishbain DA. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain. Am J Manag Care. 2008;14:S123-S128.